The Wall Street Journal (WSJ), for instance, is now selling a specially-curated programme in association with the National Geographic dubbed ‘The Future of Everything: Exploring Global Innovation by Private Jet’. In April, sworn rivals Sanofi SA and GlaxoSmithKline PLC announced a tie up to develop an adjuvanted vaccine for COVID-19, using innovative technologies that both companies have previously developed independently. The adjuvanted vaccine will potentially lower the dose needed and thus provide the vaccine to a greater number of people. In fact, the best part of such collaborations between disparate companies is seen in their combined efforts to address the pandemic. In South Africa, for instance, three different companies are working together to make hospitals safer for patients and healthcare workers.

Source: Wall Street Journal September 06, 2020 03:22 UTC